e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with
Pneumocystis
pneumonia
Shohei Hamada, Hidenori Ichiyasu, Megumi Inaba, Hiroshi Takahashi, Tomoki Sadamatsu, Kimitaka Akaike, Aiko Masunaga, Yasumasa Tashiro, Naomi Hirata, Takeshi Yoshinaga, Takuro Sakagami
Source:
ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019
Journal Issue:
April
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Shohei Hamada, Hidenori Ichiyasu, Megumi Inaba, Hiroshi Takahashi, Tomoki Sadamatsu, Kimitaka Akaike, Aiko Masunaga, Yasumasa Tashiro, Naomi Hirata, Takeshi Yoshinaga, Takuro Sakagami. Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with
Pneumocystis
pneumonia. ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients
Source: Eur Respir J 2001; 17: 87-93
Year: 2001
Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases
Source: International Congress 2017 – Rare diseases
Year: 2017
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Role of pneumocystis jiroveci in interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004
Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer
Source: Eur Respir Rev 2008; 17: 83-85
Year: 2008
Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation
Source: Eur Respir J 2010; 35: 927-929
Year: 2010
The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006
Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 526s
Year: 2001
Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Recurrence predictive factors of cryptogenic organizing pneumonia
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017
Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Prognostic evaluation of COPD patients with pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005
Clinicoradiological features of pulmonary tuberculosis associated with interstitial pneumonia
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept